News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–44
Matches
44
Sources here
5
Companies here
1
Search results Stored financial headlines

Active search

44 matching headlines

Ticker or company: CRAIMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

CRA International (NASDAQ: CRAI) awards director 989 stock shares

CRA International (NASDAQ: CRAI) director Christine Rose Detrick was granted 989 shares of common stock on July 16, 2026, as a compensation award. These shares will vest in four equal annual installments, bringing her total direct holdings to 7,128 shares. The award was reported …

CRAI main company
Sharemaestro market context Price above Trend Line 52 weeks -13.5% CRAI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CRA International (CRAI) Proxy filing Summary

CRA International (CRAI) has scheduled its annual meeting for July 16, 2026, to vote on the election of two Class I directors, executive compensation, and the ratification of Grant Thornton LLP as independent auditors. The board recommends approval of all proposals, with proxy materials …

CRAI main company
Sharemaestro market context Price above Trend Line 52 weeks -13.5% CRAI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insider Sell: Heather Tookes Sells Shares of CRA International I

Heather Tookes, a Director at CRA International Inc (CRAI), sold 124 shares of the company on July 16, 2026, bringing her total ownership to 2,817 shares. Over the past year, Tookes has sold 322 shares and made no purchases, while the company has seen …

CRAI main company
Sharemaestro market context Price above Trend Line 52 weeks -13.5% CRAI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CRA International director Heather Tookes disposes of 124 common shares for $21,490.44

CRA International director Heather Tookes sold 124 common shares for $21,490.44 on July 16, 2026, at a price of USD 173.31 per share. Following this transaction, Tookes' direct holdings in the company decreased to 2,817 shares. This news brief was generated by Public Technologies …

CRAI main company
Sharemaestro market context Price above Trend Line 52 weeks -13.5% CRAI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CRA International (NASDAQ: CRAI) director sells 124 shares under 10b5-1 plan

CRA International director Heather Tookes sold 124 shares of common stock on July 16, 2026, at $173.31 per share through a Rule 10b5-1 trading plan adopted on March 14, 2025. Following this transaction, Tookes directly holds 2,817 shares. The sale amounted to $21,490 and …

CRAI main company
Sharemaestro market context Price above Trend Line 52 weeks -13.5% CRAI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CRA International (CRAI) Q4 2025 earnings summary

CRA International (CRAI) reported a record-breaking fiscal year 2025 with $751.6 million in revenue, marking the eighth consecutive year of growth, driven by strong performance in both Legal & Regulatory Consulting and Management Consulting. Q4 2025 also set a new company record for quarterly …

CRAI main company
Sharemaestro market context Price above Trend Line 52 weeks -13.5% CRAI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

[144] CRA INTERNATIONAL, INC. SEC Filing

This article details a Form 144 SEC filing for CRA International, Inc. (CRAI), submitted on July 16, 2026. The filing indicates a proposed sale of 124 shares with an aggregate market value of $21,490.44, acquired through restricted stock vesting. The document provides standard SEC …

CRAI main company
Sharemaestro market context Price above Trend Line 52 weeks -13.5% CRAI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is CRA International (CRAI) Quietly Redefining Its Oncology Consulting Edge With The Bria-IMT Mandate?

Charles River Associates (CRA International) has been engaged by BriaCell Therapeutics to support the commercial strategy for Bria-IMT, an investigational breast cancer therapy, highlighting CRA's role in oncology commercialization. While this mandate showcases CRA's healthcare consulting reach, it doesn't significantly alter its near-term earnings …

CRAI main company
Sharemaestro market context Price above Trend Line 52 weeks -13.5% CRAI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context